Stevens‐Johnson Syndrome due to COVID‐19 vaccination

Abstract As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.

Guardado en:

Detalles Bibliográficos
Autores principales:	Parvin Mansouri, Reza Chalangari, Katalin Martits‐Chalangari, Nikoo Mozafari
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	COVID‐19 Sinopharm Stevens‐Johnson syndrome vaccinations Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/cb51d68b73404339bd4708bbd7f57f49
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cb51d68b73404339bd4708bbd7f57f49
record_format	dspace
spelling	oai:doaj.org-article:cb51d68b73404339bd4708bbd7f57f492021-12-01T06:36:08ZStevens‐Johnson Syndrome due to COVID‐19 vaccination2050-090410.1002/ccr3.5099https://doaj.org/article/cb51d68b73404339bd4708bbd7f57f492021-11-01T00:00:00Zhttps://doi.org/10.1002/ccr3.5099https://doaj.org/toc/2050-0904Abstract As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.Parvin MansouriReza ChalangariKatalin Martits‐ChalangariNikoo MozafariWileyarticleCOVID‐19SinopharmStevens‐Johnson syndromevaccinationsMedicineRMedicine (General)R5-920ENClinical Case Reports, Vol 9, Iss 11, Pp n/a-n/a (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID‐19 Sinopharm Stevens‐Johnson syndrome vaccinations Medicine R Medicine (General) R5-920
spellingShingle	COVID‐19 Sinopharm Stevens‐Johnson syndrome vaccinations Medicine R Medicine (General) R5-920 Parvin Mansouri Reza Chalangari Katalin Martits‐Chalangari Nikoo Mozafari Stevens‐Johnson Syndrome due to COVID‐19 vaccination
description	Abstract As public COVID‐19 vaccination programs are being implemented, it is possible that more rare and serious adverse effects such as Stevens‐Johnson syndrome (SJS) and toxic epidermal necrosis (TEN) may occur.
format	article
author	Parvin Mansouri Reza Chalangari Katalin Martits‐Chalangari Nikoo Mozafari
author_facet	Parvin Mansouri Reza Chalangari Katalin Martits‐Chalangari Nikoo Mozafari
author_sort	Parvin Mansouri
title	Stevens‐Johnson Syndrome due to COVID‐19 vaccination
title_short	Stevens‐Johnson Syndrome due to COVID‐19 vaccination
title_full	Stevens‐Johnson Syndrome due to COVID‐19 vaccination
title_fullStr	Stevens‐Johnson Syndrome due to COVID‐19 vaccination
title_full_unstemmed	Stevens‐Johnson Syndrome due to COVID‐19 vaccination
title_sort	stevens‐johnson syndrome due to covid‐19 vaccination
publisher	Wiley
publishDate	2021
url	https://doaj.org/article/cb51d68b73404339bd4708bbd7f57f49
work_keys_str_mv	AT parvinmansouri stevensjohnsonsyndromeduetocovid19vaccination AT rezachalangari stevensjohnsonsyndromeduetocovid19vaccination AT katalinmartitschalangari stevensjohnsonsyndromeduetocovid19vaccination AT nikoomozafari stevensjohnsonsyndromeduetocovid19vaccination
_version_	1718405505022427136

Stevens‐Johnson Syndrome due to COVID‐19 vaccination

Ejemplares similares